nephritis 发表于 2025-3-26 21:42:14

Submitted on: 25 February 2015.
Revised on: 26 March 2015.
Accepted on: 24 April 2015.

___________________INFLAMMOPHARMACOLOGY---SPRINGER BASEL AG

backdrop 发表于 2025-3-27 04:41:39

http://reply.papertrans.cn/2/126/12523/12523-32.png

废墟 发表于 2025-3-27 07:14:13

http://reply.papertrans.cn/2/126/12523/12523-33.png

Evacuate 发表于 2025-3-27 11:30:25

Submitted on: 24 October 2018.
Revised on: 12 February 2019.
Accepted on: 03 March 2019.

___________________INFLAMMOPHARMACOLOGY---SPRINGER BASEL AG

Amorous 发表于 2025-3-27 17:20:08

Submitted on: 14 April 2003.
Revised on: 25 June 2003.
Accepted on: 18 July 2003.

___________________INFLAMMOPHARMACOLOGY---SPRINGER BASEL AG

使害羞 发表于 2025-3-27 20:44:16

Submitted on: 28 March 2023.
Revised on: 21 June 2023.
Accepted on: 17 July 2023.

___________________INFLAMMOPHARMACOLOGY---SPRINGER BASEL AG
页: 1 2 3 [4]
查看完整版本: SCIE期刊INFLAMMOPHARMACOLOGY 2024/2025影响因子:4.674 (INFLAMMOPHARMACOLOGY) (0925-4692). (IMMUNOLOGY)(免疫学)Science Citation In